NCT03967262 is a NA clinical trial of Brief Motivational Intervention in Trauma, sponsored by Corporacion Parc Tauli.

Who is sponsoring NCT03967262?

NCT03967262 is sponsored by Corporacion Parc Tauli.

What drugs are being tested in NCT03967262?

Interventions in NCT03967262: Brief Motivational Intervention.

What condition does NCT03967262 study?

NCT03967262 studies Trauma, Alcohol Use, Unspecified, Drug Use.

Is NCT03967262 still recruiting?

NCT03967262 is currently status unknown. Last updated 27 January 2020.

Last reviewed 2020-01-27 · How we verify

NCT03967262

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Secondary Prevention and Recidivism Reduction in Trauma Patients

Status unknown NA Last updated 27 January 2020

What this trial tests

NA trial testing Brief Motivational Intervention in Trauma in 102 participants. Status unknown.

Timeline

1 September 2020

Primary endpoint
1 October 2022

1 October 2022

Quick facts

Lead sponsor	Corporacion Parc Tauli
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	102
Start date	1 September 2020
Primary completion	1 October 2022
Estimated completion	1 October 2022
Sites	1 location across Spain

Drugs / interventions tested

Brief Motivational Intervention

Conditions studied

Trauma — all drugs for Trauma →
Alcohol Use, Unspecified — all drugs for Alcohol Use, Unspecified →
Drug Use — all drugs for Drug Use →

Sponsor

Corporacion Parc Tauli — full company profile →

Who can join

18 and older, any sex, with Trauma or Alcohol Use, Unspecified. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The consumption of alcohol and other drugs is one of the main risk factors for traumatism. In addition, patients who have suffered an accident in relation to the consumption of these substances present a high risk of recidivism. In the case of alcohol, its relationship with traumatisms has been known for many years now and is still one of the main risk factors. Secondary prevention is an important area of action and improvement in the treatment of this type of patient by considering actions, such as a brief motivational intervention, in order to avoid recidivism. The objective of motivational intervention is to make the patient aware of the relationship between the consumption of these substances and the accident, and induce them to carry out a change in habits. The objective of the present investigation project is to determine the efficacy of secondary prevention in reducing recurrence of traumatisms. In order to this, a multicenter randomised controlled trial has been designed in which the intervention group with patients admitted for sever traumatism with positive screening for alcohol or other drugs, will be submitted to a brief motivational intervention. The main outcome will be trauma recurrence within a three year follow-up.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Brief Motivational Intervention

Trials testing the same drug.

NCT07215091 — Testing a Brief Motivational Intervention to Increase Physical Activity for Cancer Survivors · NA · recruiting
NCT03173274 — Incentives to Promote Smoking Cessation in Low SES Women · NA · terminated
NCT03357549 — Project to Promotion of Breastfeeding · NA · completed
NCT03203720 — Brief Motivational Intervention to Improve Medication Adherence for Adolescents With Bipolar Disorder · NA · completed

Other recruiting trials for Trauma

Currently open trials in the same condition.

NCT07290634 — Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion · recruiting
NCT07485231 — Nitric Oxide (NO) and Endothelial Dysfunction in Women With PTSD · NA · recruiting
NCT07473336 — The Effectiveness of RAPID-Based Psychological First Aid Training · NA · active not recruiting
NCT07278505 — Study of Cannabidiol and Neuroimaging on Stress · Phase 1, PHASE2 · recruiting
NCT02880163 — REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam · NA · recruiting

Other Corporacion Parc Tauli trials

Trials by the same sponsor.

NCT07331805 — Conservative Management in Primary Spontaneous Pneumothorax: a Multicenter Randomized Non-inferiority Study · NA · not yet recruiting
NCT06873360 — Medical Device for Oxaliplatin-Induced Neuropathy in Gastrointestinal Cancer Patients · completed
NCT06900335 — Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic Impact · completed
NCT06511700 — Implementation of the Intravitreal Injection Administered by Nurses · enrolling by invitation
NCT07298720 — Assessing Fluid-responsiveness Using Non-invasive Hybrid Diffuse Optics on Peripheral Muscle · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03967262 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Corporacion Parc Tauli
Last refreshed: 27 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03967262.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing